Business
Crystal Research Associates Issues Updated Report on BELLUS Health Inc.
Crystal Research Associates Issues Updated Report on BELLUS Health Inc.
About this update from Bluenergies Ltd.
[{"type":"text","content":"\nCrystal Research Associates Issues Updated Report on BELLUS Health Inc.\n\n\n Dec. 16, 2010 (Baystreet.ca) -- Disease-Modifying Pharmaceutical Treatments and Nutraceuticals New York -- Crystal Research Associates, LLC announced today that it has issued an updated Executive Informational Overview® (EIO®) on BELLUS Health Inc. (BLU-TSX). The full 44-page report can be found at www.crystalra.com.BELLUS Health Inc. (\"BELLUS Health\" or \"the Company\") is a global health company focused on the research and development of innovative health solutions for critical, unmet medical needs. The Company's pharmaceutical pipeline targets disorders for which there are no known cures. BELLUS Health's most advanced pharmaceutical candidate is KIACTA (eprodisate) to treat Amyloid A (AA) amyloidosis, a disease marked by an abnormal accumulation of certain proteins that can cause organ dysfunction, organ failure, and even death. In December 2010, KIACTA entered a confirmatory Phase III trial funded by Celtic Therapeutics, a global private equity firm, under an April 2010 agreement between BELLUS Health and Celtic. The Company's pharmaceutical pipeline also includes NRM8499, a prodrug for Alzheimer's disease (AD) that entered a Phase I trial in March 2010.Additionally, through a wholly owned subsidiary, OVOS Natural Health Inc., the Company markets a clinically tested nutraceutical called VIVIMIND (tramiprosate/homotaurine) to protect memory function. VIVIMIND is available online and has been granted approval for sale in Canada, Italy, and Spain.Be the first to hear about Crystal Research's new report releases and upcoming media coverage. Follow us on Twitter at http://www.twitter.com/crystalresearch or visit our blog to stay up-to-date on industry and company news for clients under our research coverage.About Crystal Research Associates, LLC Crystal Research Associates, LLC is an independent research firm that provides institutional-quality research on small- and mid-cap companies. The firm is led by veteran Wall Street sell-side analyst Jeffrey Kraws, who is well known by the international financial media for his years of work on Wall Street and for providing consistent award-winning analyses and developing long-term relationships on both the buy-side and sell-side. He has been consistently ranked on Wall Street among the Top Ten Anal...